Accueil > Actualité
Actualite financiere : Actualite bourse

J&J: Crohn's disease drug shows encouraging results

(CercleFinance.com) - New phase 3b data has showed that two-thirds of patients with Crohn's disease achieved clinical remission after two doses of Janssen's ustekinumab, the J&J unit said on Friday.


At week 16, 79% of patients with moderately to severely active Crohn's disease achieved clinical response and 67% were in clinical remission after receiving one intravenous dose, followed by one subcutaneous dose of the drug, Janssen said.

The analysis, which includes 500 participants, is the first study to explore a treatment strategy using endoscopy to guide dose adjustment.

Copyright (c) 2020 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.